Cargando…
The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15
Cardiometabolic syndrome has become a global health issue. Heart failure is a common comorbidity of cardiometabolic syndrome. Successful drug development to prevent cardiometabolic syndrome and associated comorbidities requires preclinical models predictive of human conditions. To characterize the h...
Autores principales: | Stolina, Marina, Luo, Xin, Dwyer, Denise, Han, Chun-Ya, Chen, Rhonda, Zhang, Ying, Xiong, YuMei, Chen, Yinhong, Yin, Jun, Shkumatov, Artem, Ason, Brandon, Hale, Clarence, Véniant, Murielle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430742/ https://www.ncbi.nlm.nih.gov/pubmed/32804947 http://dx.doi.org/10.1371/journal.pone.0231234 |
Ejemplares similares
-
Effects of soluble guanylate cyclase stimulator on renal function in ZSF-1 model of diabetic nephropathy
por: Hu, Lufei, et al.
Publicado: (2022) -
Growth differentiation factor 15 as a potential therapeutic for treating obesity
por: Hale, Clarence, et al.
Publicado: (2020) -
Chamber-enriched gene expression profiles in failing human hearts with reduced ejection fraction
por: Luo, Xin, et al.
Publicado: (2021) -
Stigmasterol accumulation causes cardiac injury and promotes mortality
por: Tao, Caroline, et al.
Publicado: (2019) -
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
por: Lu, Shu-Chen, et al.
Publicado: (2021)